John A Bullock

Title: John A Bullock: Innovator in Pharmaceutical Evaluation Methods

Introduction

John A Bullock is a notable inventor based in King of Prussia, PA (US). He has made significant contributions to the field of pharmaceutical sciences, particularly in the evaluation of dosage forms. With a total of 3 patents to his name, Bullock's work focuses on improving the effectiveness of drug formulations.

Latest Patents

Bullock's latest patents include innovative in vitro methods for evaluating the in vivo effectiveness of dosage forms of microparticulate or nanoparticulate active agent compositions. These methods are designed to assess the redispersibility of dosage forms containing poorly water-soluble active agents. The techniques utilize media that accurately represent in vivo human physiological conditions, thereby enhancing the reliability of the evaluation process.

Career Highlights

Throughout his career, John A Bullock has worked with prominent companies in the pharmaceutical industry, including Elan Pharma International Limited and Alkermes Pharma Ireland Limited. His experience in these organizations has allowed him to develop and refine his innovative approaches to drug formulation and evaluation.

Collaborations

Some of his notable coworkers include Eugene Rex Cooper and John R Chippari. Their collaborative efforts have contributed to advancements in the pharmaceutical field, further enhancing the impact of Bullock's inventions.

Conclusion

John A Bullock's contributions to pharmaceutical evaluation methods demonstrate his commitment to improving drug effectiveness. His innovative patents and collaborations reflect his significant role in advancing the field of pharmaceutical sciences.